Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.389
+0.012 (3.10%)
At close: Oct 29, 2024, 4:00 PM
0.382
-0.007 (-1.75%)
After-hours: Oct 29, 2024, 7:04 PM EDT
Aethlon Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Oct '24 Oct 29, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 5 | 4 | 9 | 22 | 25 | 14 | |
| Market Cap Growth | -22.25% | -49.89% | -60.95% | -8.59% | 72.90% | -20.97% | |
| Enterprise Value | -3 | -3 | -7 | 2 | 12 | 10 | |
| Last Close Price | 0.38 | 1.68 | 3.83 | 14.60 | 20.30 | 15.20 | |
| PE Ratio | - | -0.35 | -0.65 | -2.07 | -3.11 | -0.81 | |
| PS Ratio | - | - | 15.30 | 76.47 | 37.34 | 21.89 | |
| PB Ratio | 0.61 | 0.76 | 0.58 | 1.32 | 2.65 | 1.53 | |
| P/FCF Ratio | -0.74 | -0.42 | -0.77 | -2.22 | -3.61 | -2.66 | |
| P/OCF Ratio | -0.74 | -0.43 | -0.84 | -2.30 | -3.64 | -2.74 | |
| EV/Sales Ratio | - | - | -12.96 | 7.82 | 18.83 | 15.70 | |
| EV/EBITDA Ratio | -0.23 | 0.22 | 0.64 | -0.22 | -1.58 | -1.73 | |
| EV/EBIT Ratio | -0.22 | 0.22 | 0.63 | -0.22 | -1.57 | -1.72 | |
| EV/FCF Ratio | -0.26 | 0.25 | 0.65 | -0.23 | -1.82 | -1.91 | |
| Debt / Equity Ratio | 0.10 | 0.16 | 0.08 | 0.04 | 0.00 | 0.02 | |
| Debt / FCF Ratio | -0.09 | -0.09 | -0.11 | -0.07 | -0.01 | -0.03 | |
| Asset Turnover | - | - | 0.03 | 0.02 | 0.06 | 0.09 | |
| Quick Ratio | 4.26 | 2.97 | 9.66 | 9.43 | 7.28 | 9.19 | |
| Current Ratio | 4.49 | 3.40 | 10.03 | 9.95 | 7.53 | 9.40 | |
| Return on Equity (ROE) | -105.38% | -117.21% | -75.06% | -79.29% | -84.99% | -110.22% | |
| Return on Assets (ROA) | -50.46% | -57.15% | -40.28% | -43.29% | -46.85% | -51.08% | |
| Return on Capital (ROIC) | -57.62% | -64.05% | -43.75% | -48.14% | -52.60% | -58.46% | |
| Earnings Yield | -217.15% | -277.32% | -136.92% | -46.30% | -32.05% | -44.78% | |
| FCF Yield | -177.82% | -235.80% | -130.30% | -44.97% | -27.73% | -37.58% | |
| Buyback Yield / Dilution | -65.73% | -22.35% | -39.17% | -22.05% | -254.07% | -182.61% | |
| Total Shareholder Return | -65.73% | -22.35% | -39.17% | -22.05% | -254.07% | -182.61% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.